« Return to News | CROs/Service Providers | Ethics/Regulatory

Top Stories for the Week of August 27th 2007

Friday, August 31, 2007 07:52 AM

Top News

 

First Locally Owned, Black-Empowered CRO Launches in South Africa

African Clinical Research Organisation (ACRO), the first locally owned, black-empowered full-service contract research organization (CRO) in Johannesburg, South Africa, launched this month.

Quorum Opens IRB Services in Canada with New Board

Sponsors who conduct multicenter clinical trials in the United States typically include some Canadian sites. These projects are often tied into a single North American program. Seeing this trend for many years, Seattle, Wash.-based independent review board (IRB) Quorum Review decided to create a new North American ethics review board capable of offering its clients services for Canadian trials.

Other breaking news...      

  • Averion reports net operating loss for second quarter...
  • KineMed extends alliance with CMIC...

Company Profile: An interview with Michael Spigarelli, medical director, Cincinnati Children's Research Foundation

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.